HAP1A Inhibitors
HAP1A inhibitors are a class of chemical compounds that specifically target and modulate the activity of Huntingtin-associated protein 1A (HAP1A). HAP1A is one of the two isoforms of HAP1, a cytoplasmic protein that plays a role in intracellular trafficking, endocytosis, and signal transduction pathways. HAP1A is particularly involved in the stabilization of proteins such as receptors and ion channels, helping to regulate their cellular localization and function. HAP1A inhibitors disrupt these interactions by interfering with the protein's binding affinity for its partners or by altering its conformation, thereby preventing its normal function in cellular processes. These inhibitors provide insights into the structural dynamics of HAP1A, allowing for a better understanding of its role in cellular homeostasis and protein stability.
The design and development of HAP1A inhibitors often rely on structure-based drug design techniques, where the binding sites of HAP1A are analyzed and targeted with small molecules that can effectively inhibit its activity. Inhibitors may work by competing with natural ligands for binding or by inducing conformational changes that block the protein's interaction with other cellular components. These compounds are valuable in research settings for studying the molecular pathways in which HAP1A is involved, such as vesicular trafficking and intracellular transport. Through selective inhibition, researchers can dissect the specific functions of HAP1A in various cellular contexts, making these inhibitors essential tools for probing the mechanisms underlying HAP1A-associated molecular interactions.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could downregulate HAP1A expression by inhibiting histone deacetylase, resulting in hyperacetylation of histones and a subsequent change in the expression of genes, including the one encoding HAP1A. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This compound may decrease HAP1A levels by reducing DNA methylation levels, which may lead to an upregulation of genes that suppress HAP1A expression or a decrease in methylation on the HAP1A gene promoter itself. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Suberoylanilide Hydroxamic Acid may lead to a reduction in HAP1A expression by histone deacetylase inhibition, which could cause an open chromatin structure at the HAP1A gene locus, making it less transcriptionally active. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
By binding to GC-rich sequences of DNA, Mithramycin A might inhibit the binding of transcription factors to the promoter region of the HAP1A gene, thereby decreasing its transcription. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D can decrease transcription levels of HAP1A by intercalating into DNA, which would obstruct the elongation phase of RNA polymerase movement along the HAP1A gene. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin could reduce HAP1A expression through inhibition of the mTOR signaling pathway, which is involved in cellular growth and protein synthesis, including that of HAP1A. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide may decrease HAP1A protein levels by blocking the translocation step in protein synthesis, which would nonspecifically inhibit the synthesis of proteins, including HAP1A. | ||||||
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
Doxorubicin could potentially downregulate HAP1A expression by intercalating into DNA, disrupting the replication and transcription machinery at the HAP1A gene locus. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
By inhibiting topoisomerase I, Camptothecin might prevent the religation of single-strand breaks during transcription, which could decrease HAP1A gene expression due to transcription stress and DNA damage responses. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine might inhibit HAP1A expression by intercalating into the DNA and RNA, which could disrupt the transcriptional machinery or alter mRNA stability of the HAP1A gene. | ||||||